ArticleJournal of medicinal chemistry2024

Development of Highly Potent, G-Protein Pathway Biased, Selective, and Orally Bioavailable GPR84 Agonists.

Pinqi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.